Main Article Content

Dr Noor Ul Ain
Dr Aakif Ullah Khan
Dr Abbas Ilyas
Dr Sami Ullah
Dr Imran Farooq
Dr Sana Ullah
Dr Zainab Jan
Asad Zamir
Dr Naheed Akhtar



Introduction: Due to its rarity, male breast cancer remains a poorly characterized disease and is managed on the guidelines of female breast cancer. We present data of 56 male breast cancer patients treated at the Institute of Radiotherapy and Nuclear Medicine (IRNUM) in Peshawar, Pakistan during year 2018-2022.

Methods: A retrospective cross-sectional study was conducted at IRNUM Peshawar Pakistan, of male patients registered  1-1-2018 and 31-12-2022.

Results: A total of 56 male patients who presented over a period of 05 years were included. The most common tumor type was invasive ductal carcinoma (96.4%). The majority (36.8%) of the patients presented at stage III. Among the 56 patients who underwent surgery, only one patient had invasive lobular histopathology while one patient had Papillary CA variant. 31 out of the 56 patients (55%) were grade II while 25 patients (44.6%) were Grade III. Additionally, the majority of patients were pathologic stage III (n = 45/56, 80.4%), followed by stage IV (n = 11/46, 19.6%). Of the 48 cases that underwent molecular studies had estrogen receptor positivity, where 4 (8.3%) were human epidermal growth factor receptor 2 (Her 2+ive) while 44 (91.6%) were Her –ive.

Conclusion: Breast cancer in males presents at an advanced stage with poor survival. Multicenter studies are required to accurately identify incidence, prognostic factors, and outcomes in order to have a better understanding of its management.

Abstract 51 | PDF Downloads 32


1. Aygin D, Cengiz H: Life quality of patients who underwent breast reconstruction after prophylactic mastectomy: systematic review. Breast Cancer. 2018, 25:497-505.
2. Miao H, Verkooijen HM, Chia KS, et al.: Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol. 2011, 29:4381-6.
3. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN: Breast carcinoma in men: a populationbased study. Cancer. 2004, 101:51-7.
4. English, J. C., Middleton, C., Patterson, J. W. & Slingluff, C. L. Cancer of the male breast. Int. J. Dermatol. 2000, 39(12), 881–886.
5. Yu, X. F., Yang, H. J., Yu, Y., Zou, D. H. & Miao, L. L. A prognostic analysis of male breast cancer (MBC) compared with post-menopausal female breast cancer (FBC). PLoS ONE, 2015 10(8), 0136670.
6. Pant, K. & Dutta, U. Understanding and management of male breast cancer: A critical review. Med. Oncol. 2008, 25(3), 294–298.
7. Vetto, J., Jun, S. Y., Paduch, D., Eppich, H. & Shih, R. Stages at presentation, prognostic factors, and outcome of breast cancer in males. Am. J. Surg. 1999, 177(5), 379–383.
8. Zeeshan, S., Siddiqiui, T., Shaukat, F., Tariq, M. U., Khan, N., & Vohra, L. Male Breast Cancer: The Three Decades' Experience of a Tertiary Care Hospital in a Lower-Middle Income Country. Cureus, 2022, 14(2), 22670.
9. Chikaraddi SB, Krishnappa R, Deshmane V: Male breast cancer in Indian patients: is it the same? . Indian J Cancer. 2012, 49:272-6.
10. Rai B, Ghoshal S, Sharma SC: Breast cancer in males: a PGIMER experience . J Cancer Res Ther. 2005, 1:31-3.
11. Korde LA, Zujewski JA, Kamin L, et al.: Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010, 28:2114-22.
12. Khokher S, Qureshi MU, Riaz M, Akhtar N, Saleem A: Clinicopathologic profile of breast cancer patients in Pakistan: ten years data of a local cancer hospital. Asian Pac J Cancer Prev. 2012, 13:693-8.
13. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M: Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006, 56:168-83.
14. Camarillo I, Thulasidas JS, Poompavai S, et al.: Male breast cancer: another look. Gaz Med Sci. 2021, 2:15-29.
15. Sharif MA, Mamoon N, Arif A, et al.: Histological and immuno-histochemical study of male breast carcinoma in Northern Pakistan. J Pak Med Assoc. 2009, 59:67-71.

Most read articles by the same author(s)